Our flagship diagnostic device, WoundSweep™, is designed to revolutionize the management of chronic, non-healing wounds. By pairing our gentle, minimally invasive tissue sampling technology with advanced protein biomarker analysis, we empower clinicians with the critical molecular data needed to move beyond subjective visual assessments.

Chronic wounds frequently stall in a dysregulated inflammatory state, characterized by elevated levels of matrix metalloproteinases (MMPs) and pro-inflammatory cytokines that destroy healthy tissue and growth factors. WoundSweep provides an objective, molecular window into this stalled state. By precisely identifying the biochemical barriers preventing closure, our technology enables targeted interventions—such as protease modulation or advanced biologic therapies—ensuring the right treatment is applied at the exact right time.

Backed by decades of combined expertise in wound biology, genomics, and clinical practice, Diapeutic is committed to eliminating trial-and-error medicine and restoring skin health through precision diagnostics.